title: [Controversy. Dabigatran in the preventive treatment of embolic stroke: arguments in favour of its utilisation as a first-choice drug].
authors.affiliation: Hospital Universitario Ramon y Cajal, Madrid, Espana. jmasjuan.hrc@salud.madrid.org
authors.forename: J
authors.initials: J
authors.lastname: Masjuan
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D000069604:Dabigatran; D006801:Humans; D020766:Intracranial Embolism / Q000150:complications / Q000517:prevention & control*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D015091:beta-Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran